Dose-dense chemotherapy with the CODE combination (CDDP–VCR–ADM–ETP) and addition of granulocyte colony-stimulating factor (G-CSF) can be safely administered to patients with advanced lung cancer (Murray et al, 1991; Fukuoka et al, 1997). Here, CSF3 is linked to lung cancer.